Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro.

MLA

Nishiyama, Takashi, et al. “Antiviral Candidates against the Hepatitis E Virus (HEV) and Their Combinations Inhibit HEV Growth in in Vitro.” Antiviral Research, vol. 170, Oct. 2019, p. 104570. EBSCOhost, https://doi.org/10.1016/j.antiviral.2019.104570.

APA

Nishiyama, T., Kobayashi, T., Jirintai, S., Nagashima, S., Primadharsini, P. P., Nishizawa, T., & Okamoto, H. (2019). Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro. Antiviral Research, 170, 104570. https://doi.org/10.1016/j.antiviral.2019.104570

Chicago

Nishiyama, Takashi, Tominari Kobayashi, Suljid Jirintai, Shigeo Nagashima, Putu Prathiwi Primadharsini, Tsutomu Nishizawa, and Hiroaki Okamoto. 2019. “Antiviral Candidates against the Hepatitis E Virus (HEV) and Their Combinations Inhibit HEV Growth in in Vitro.” Antiviral Research 170 (October): 104570. doi:10.1016/j.antiviral.2019.104570.